Appropriate Dose of Neostigmine for Reversal of Rocuronium and Cisatracurium
NCT01885715
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
112
Enrollment
OTHER
Sponsor class
Conditions
Observation of Neuromuscular Block
Interventions
DRUG:
Injection of neostigmine
Sponsor
Seoul National University Hospital